GenDx introduces a new journal club webinar focused on critically appraising the latest publications and evidence in transplant surveillance. In this inaugural kidney transplant session, we will review key studies published over the last couple of years, discuss their clinical relevance, and explore how recent findings may influence patient management and future research directions.
This session will be hosted by Valentina M. Zinna, Medical Science Liaison EMEA, Medical Affairs at GenDx. Sessions will be held in English and, for the first time, in Spanish.
About the topic:
The evidence supporting the use of donor-derived cell-free DNA (dd-cfDNA) in kidney transplantation continues to evolve rapidly, with numerous studies published in recent years expanding our understanding of its clinical utility. From post-transplant surveillance and assessment of allograft injury to risk stratification and integration with other biomarkers, new data are shaping how dd-cfDNA may be incorporated into post-transplant monitoring strategies.
Join us for an interactive discussion designed to translate the newest evidence into practical insights for clinicians, scientists, and transplant professionals. Attend the webinar and receive 0.15 continuing education credits (CECs).
🗣️Register for the session in Spanish (October 21, 2026, 17:00 CEST)